Indivior to appoint Lizabeth Zlatkus as non-executive director
Speciality pharmaceuticals firm Indivior will appoint Lizabeth Zlatkus as an independent non-executive director with effect from 1 September.
Cboe UK 250
1,512.50
17:00 18/05/16
Indivior
779.50p
15:55 15/11/24
In a statement to the London Stock Exchange on Thursday, the company said Zlatkus will also become a member of its audit committee.
She spent a significant part of her career with Hartford Financial Services Group, one of the largest insurance and investment companies in the US, where she held a number of senior leadership positions including chief financial officer and chief risk officer.
Prior to joining Hartford, Zlatkus was a senior accountant with KPMG and is also a non-executive director of Legal & General Group and Boston Private Financial Holdings.
At 1613 BST, Indivior's share price was up 0.80p or 0.48% to 167.60p.